news COVID-19 viral envelope simulation under development 25 March 2020 | By Hannah Balfour (Drug Target Review) Researchers are working to build a complete, all-atom model of the exterior of the coronavirus to aid in drug design.
news Map of COVID-19 and human protein interactions reveals drug targets 24 March 2020 | By Victoria Rees (Drug Target Review) Researchers have identified which SARS-CoV-2 proteins physically associate with proteins in human cells, revealing potential drug targets to treat the COVID-19 coronavirus.
news Chronic use of heart disease medications may increase the risk of severe COVID-19 24 March 2020 | By Hannah Balfour (Drug Target Review) A researcher has revealed that angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARBs) may increase the risk of severe lung complications in COVID-19.
news Researchers to screen compound library for antiviral drugs to combat COVID-19 23 March 2020 | By Victoria Rees (Drug Target Review) Scripps Research has announced it will screen over 14,000 compounds to see if any present significant activity against COVID-19, for use in a therapeutic.
news Preliminary SARS-CoV-2 protease inhibitor shows efficacy in mice 20 March 2020 | By Victoria Rees (Drug Target Review) Using X-ray crystallography, researchers have revealed the structure of the SARS-CoV-2 main protease, designing an inhibitor to bind to this target and prevent viral replication.
news Mapping the immune response to COVID-19 17 March 2020 | By Hannah Balfour (Drug Target Review) Researchers reveal that a broad range of immune cells react to COVID-19 and aid recovery, findings which could inform the development of a potential vaccine.
news Scientists demonstrate how COVID-19 infects human cells 5 March 2020 | By Hannah Balfour (Drug Target Review) Researchers have used cryogenic electron microscopy to show that coronaviruses enter human cells through an interaction with angiotensin-converting enzyme 2 (ACE2).
news Researchers map vital atomic-scale protein on COVID-19 20 February 2020 | By Victoria Rees (Drug Target Review) Using cryogenic electron microscopy, a team has mapped the Spike protein on COVID-19, which could be used in the development of vaccines.